Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Prosperini

Showing results (41-50 of 182) with videos related to

Pageof 19
Sort By:
European Journal of Neurology|March 3, 2021
Ozone-induced encephalopathy: A novel iatrogenic entityShalom Haggiag, Luca Prosperini, Alessandro Stasolla, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 12, 2010
The use of ID migraine™ questionnaire in patients with multiple sclerosisVeronica Villani, Luca Prosperini, Carlo Pozzilli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 13, 2010
Visuo-proprioceptive training reduces risk of falls in patients with multiple sclerosisLuca Prosperini, Laura Leonardi, Paolo De Carli, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 3, 2014
Sustained disability improvement is associated with T1 lesion volume shrinkage in natalizumab-treated patients with multiple sclerosisLuca Prosperini, Floriana De Angelis, Rosanna De Angelis, et al.
Journal of Neurology|September 17, 2021
Increased risk of death from COVID-19 in multiple sclerosis: a pooled analysis of observational studiesLuca Prosperini, Carla Tortorella, Shalom Haggiag, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 16, 2025
Cost-Minimization Analysis and Budget Impact Analysis About Subcutaneous Natalizumab in Relapsing-Remitting Multiple Sclerosis in ItalyLuca Prosperini, Lorenzo Pradelli, Laura Santoni, et al.
BMC Neurology|March 1, 2011
Management of breakthrough disease in patients with multiple sclerosis: when an increasing of Interferon beta dose should be effective?Luca Prosperini, Giovanna Borriello, Laura De Giglio, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 3, 2017
Determinants of botulinum toxin discontinuation in multiple sclerosis: a retrospective studyPamela Latino, Letizia Castelli, Luca Prosperini, et al.
Neurorehabilitation and Neural Repair|March 13, 2013
Home-based balance training using the Wii balance board: a randomized, crossover pilot study in multiple sclerosisLuca Prosperini, Deborah Fortuna, Costanza Giannì, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 25, 2017
Lesion symptom map of cognitive-postural interference in multiple sclerosisSerena Ruggieri, Fulvia Fanelli, Letizia Castelli, et al.
Pageof 19

Showing results (41-50 of 182) with videos related to

Sort By:
Pageof 19
European Journal of Neurology|March 3, 2021
Ozone-induced encephalopathy: A novel iatrogenic entityShalom Haggiag, Luca Prosperini, Alessandro Stasolla, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 12, 2010
The use of ID migraine™ questionnaire in patients with multiple sclerosisVeronica Villani, Luca Prosperini, Carlo Pozzilli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 13, 2010
Visuo-proprioceptive training reduces risk of falls in patients with multiple sclerosisLuca Prosperini, Laura Leonardi, Paolo De Carli, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 3, 2014
Sustained disability improvement is associated with T1 lesion volume shrinkage in natalizumab-treated patients with multiple sclerosisLuca Prosperini, Floriana De Angelis, Rosanna De Angelis, et al.
Journal of Neurology|September 17, 2021
Increased risk of death from COVID-19 in multiple sclerosis: a pooled analysis of observational studiesLuca Prosperini, Carla Tortorella, Shalom Haggiag, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 16, 2025
Cost-Minimization Analysis and Budget Impact Analysis About Subcutaneous Natalizumab in Relapsing-Remitting Multiple Sclerosis in ItalyLuca Prosperini, Lorenzo Pradelli, Laura Santoni, et al.
BMC Neurology|March 1, 2011
Management of breakthrough disease in patients with multiple sclerosis: when an increasing of Interferon beta dose should be effective?Luca Prosperini, Giovanna Borriello, Laura De Giglio, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 3, 2017
Determinants of botulinum toxin discontinuation in multiple sclerosis: a retrospective studyPamela Latino, Letizia Castelli, Luca Prosperini, et al.
Neurorehabilitation and Neural Repair|March 13, 2013
Home-based balance training using the Wii balance board: a randomized, crossover pilot study in multiple sclerosisLuca Prosperini, Deborah Fortuna, Costanza Giannì, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 25, 2017
Lesion symptom map of cognitive-postural interference in multiple sclerosisSerena Ruggieri, Fulvia Fanelli, Letizia Castelli, et al.
Pageof 19